Showing results (1-10 of 158) with videos related to
Sort By:
Pageof 16
The New England Journal of Medicine|November 15, 2013
Case of the Massachusetts General Hospital: Case 35-2013: a 77-year-old man with confusion and malaiseJeffrey A Barnes, Jeremy S Abramson, James A Scott, et al.Cancer|June 22, 2010
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphomaJeremy S Abramson, Matthew Hellmann, Jeffrey A Barnes, et al.The Oncologist|April 15, 2006
T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and managementJeremy S AbramsonCancer|July 10, 2019
Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?Jeremy S AbramsonHematology/Oncology Clinics of North America|November 28, 2016
The Spectrum of Double Hit LymphomasJeremy S AbramsonClinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Transformative Clinical Trials in Non-Hodgkin and Hodgkin LymphomasJeremy S AbramsonTransfusion Medicine Reviews|November 4, 2019
Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin LymphomaJeremy S AbramsonJournal of the National Comprehensive Cancer Network : JNCCN|November 26, 2019
Diagnosis and Management of Castleman DiseaseJeremy S AbramsonHematological Oncology|June 30, 2018
Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II studyJeffrey A Barnes, Robert Redd, David C Fisher, et al.Leukemia & Lymphoma|October 8, 2024
Double hit lymphoma: contemporary understanding and practicesEashwar Somasundaram, Jeremy S AbramsonPageof 16